UCLA Mouse Study Offers Hope For Correcting How Autism Disrupts Brain
Jun 30th 2008Drug InformationAutism
UCLA researchers discovered that an FDA-approved drug reverses the brain dysfunction inflicted by a genetic disease called tuberous sclerosis complex (TSC). Because half of TSC patients also suffer from autism, the findings offer new hope for addressing learning disorders due to autism. Nature Medicine publishes the findings in its online June 22 edition.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
